Tens of thousands of junior doctors who allege they were systemically underpaid have reached a $230 million settlement with NSW Health, the largest settlement ever in an underpayments class action.
Sydney lawyer and wealth guru Dominique Grubisa is challenging a finding in an ACCC case that her seminars made misleading statements and has sought to pause the court action until her appeal is heard, a bid a judge has warned won’t be “favourably received” by him.
Former AMA Group CEO Andrew Hopkins has agreed to pay the car repair giant a confidential sum to settle claims he defrauded the company of $3 million and breached his fiduciary duties.
A judge has expressed concern that a “bizarre” last-minute settlement in a long-running case against the CFMEU could damage the public perception of the FWO as a model litigant, saying it could appear that the ombudsman treated some perpetrators as “more equal” than others.
Gordon Legal is investigating a possible class action related to alleged misconduct by a late Melbourne lawyer on behalf of people who provided “large sums of money” to him and his suburban legal practice.
A subsidiary of hospitality giant Mantle Group has failed to set aside a Fair Work Commission decision finding it systematically underpaid employees and gave “knowingly false” evidence, with an appeals court refusing to find the decision gave rise to the appearance of bias.
Australians who sank $21.2 million into crypto firm NGS Crypto, including their retirement savings, may have been misled about the safety of their investments, according to an investigation by the Australian Securities and Investments Commission.
Macquarie Bank has agreed to pay a $10 million fine in proceedings brought ASIC after the bank admitted that it failed to monitor third-party withdrawals, resulting in a financial adviser’s theft of $2.9 million.
A judge has signed off on a $16 million settlement in a class action against Dixon Advisory, but the funder of a competing case that was stayed after losing a beauty parade has earned a fragment of the $1 million it sought from the resolution sum.
After a seven-year legal battle, a court has upheld the validity of Neurim Pharmaceutical’s patent for insomnia drug Circadin and ruled two generic drug companies infringed the intellectual property.